Clinical Trial Update: International Trial of the Efficacy and Safety of BCD-100 in Patients With Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for BCD-100 in patients with melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• BCD-100 (unclear)

Snippet

Sponsor: Biocad | Conditions: Melanoma | Phase 2 | Status: UNKNOWN